Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis

被引:551
作者
Davis, HR
Zhu, LJ
Hoos, LM
Tetzloff, G
Maguire, M
Liu, JJ
Yao, XR
Iyer, SPN
Lam, MH
Lund, EG
Detmers, PA
Graziano, MP
Altmann, SW
机构
[1] Schering Plough Corp, Res Inst, Dept Cardiovasc Metab Dis, Kenilworth, NJ 07033 USA
[2] Schering Plough Corp, Res Inst, Dept Discovery Technol, Kenilworth, NJ 07033 USA
[3] Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ 07065 USA
[4] Merck Res Labs, Dept Immunol, Rahway, NJ 07065 USA
关键词
D O I
10.1074/jbc.M405817200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Niemann-Pick C1 Like 1 (NPC1L1) is a protein localized in jejunal enterocytes that is critical for intestinal cholesterol absorption. The uptake of intestinal phytosterols and cholesterol into absorptive enterocytes in the intestine is not fully defined on a molecular level, and the role of NPC1L1 in maintaining whole body cholesterol homeostasis is not known. NPC1L1 null mice had substantially reduced intestinal uptake of cholesterol and sitosterol, with dramatically reduced plasma phytosterol levels. The NPC1L1 null mice were completely resistant to diet-induced hypercholesterolemia, with plasma lipoprotein and hepatic cholesterol profiles similar to those of wild type mice treated with the cholesterol absorption inhibitor ezetimibe. Cholesterol/cholate feeding resulted in down-regulation of intestinal NPC1L1 mRNA expression in wild type mice. NPC1L1 deficiency resulted in up-regulation of intestinal hydroxymethylglutaryl-CoA synthase mRNA and an increase in intestinal cholesterol synthesis, down-regulation of ABCA1 mRNA, and no change in ABCG5 and ABCG8 mRNA expression. NPC1L1 is required for intestinal uptake of both cholesterol and phytosterols and plays a major role in cholesterol homeostasis. Thus, NPC1L1 may be a useful drug target for the treatment of hypercholesterolemia and sitosterolemia.
引用
收藏
页码:33586 / 33592
页数:7
相关论文
共 22 条
[1]   Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption [J].
Altmann, SW ;
Davis, HR ;
Zhu, LJ ;
Yao, XR ;
Hoos, LM ;
Tetzloff, G ;
Iyer, SPN ;
Maguire, M ;
Golovko, A ;
Zeng, M ;
Wang, LQ ;
Murgolo, N ;
Graziano, MP .
SCIENCE, 2004, 303 (5661) :1201-1204
[2]   The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption [J].
Altmann, SW ;
Davis, HR ;
Yao, XR ;
Laverty, M ;
Compton, DS ;
Zhu, LJ ;
Crona, JH ;
Caplen, MA ;
Hoos, LM ;
Tetzloff, G ;
Priestley, T ;
Burnett, DA ;
Strader, CD ;
Graziano, MP .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1580 (01) :77-93
[3]   Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters [J].
Berge, KE ;
Tian, H ;
Graf, GA ;
Yu, LQ ;
Grishin, NV ;
Schultz, J ;
Kwiterovich, P ;
Shan, B ;
Barnes, R ;
Hobbs, HH .
SCIENCE, 2000, 290 (5497) :1771-1775
[4]   The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines [J].
Bortnick, AE ;
Rothblat, GH ;
Stoudt, G ;
Hoppe, KL ;
Royer, LJ ;
McNeish, J ;
Francone, OL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28634-28640
[5]   Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice [J].
Buhman, KK ;
Accad, M ;
Novak, S ;
Choi, RS ;
Wong, JS ;
Hamilton, RL ;
Turley, S ;
Farese, RV .
NATURE MEDICINE, 2000, 6 (12) :1341-1347
[6]   DEMONSTRATION OF A DIRECT EFFECT ON HEPATIC ACYL COA-CHOLESTEROL ACYL TRANSFERASE (ACAT) ACTIVITY BY AN ORALLY-ADMINISTERED ENZYME-INHIBITOR IN THE HAMSTER [J].
BURRIER, RE ;
DEREN, S ;
MCGREGOR, DG ;
HOOS, LM ;
SMITH, AA ;
DAVIS, HR .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (09) :1545-1551
[7]   Evidence for a Niemann-Pick C (NPC) gene family: Identification and characterization of NPC1L1 [J].
Davies, JP ;
Levy, B ;
Ioannou, YA .
GENOMICS, 2000, 65 (02) :137-145
[8]   Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice [J].
Davis, HR ;
Compton, DS ;
Hoos, L ;
Tetzloff, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) :2032-2038
[9]   The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs [J].
Davis, HR ;
Pula, KK ;
Alton, KB ;
Burrier, RE ;
Watkins, RW .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (10) :1234-1241
[10]   Efficacy and safety of Ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia [J].
Gagné, C ;
Bays, HÉ ;
Weiss, SR ;
Mata, P ;
Quinto, K ;
Melino, M ;
Cho, M ;
Musliner, TA ;
Gumbiner, B .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10) :1084-1091